Browse

You are looking at 201 - 250 of 1,314 items for :

  • Clinical Resources x
  • Refine by Access: All content x
Clear All
Restricted access

Vancomycin Hydrochloride

Michelle C. Simpson and Eric G. Schaefer

Restricted access

VinBLAStine Sulfate

Michelle C. Simpson and Eric G. Schaefer

Restricted access

VinCRIStine Sulfate

Michelle C. Simpson and Eric G. Schaefer

Restricted access

Vinorelbine Tartrate

Michelle C. Simpson and Eric G. Schaefer

Restricted access

Voriconazole

Michelle C. Simpson and Eric G. Schaefer

Restricted access

Ziconotide Acetate

Michelle C. Simpson and Eric G. Schaefer

Restricted access

Zidovudine

Michelle C. Simpson and Eric G. Schaefer

Restricted access

Zoledronic Acid

Michelle C. Simpson and Eric G. Schaefer

Restricted access

Acetaminophen Suspension 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Free access

Acetazolamide Suspension 25 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Acetazolamide Suspension 25 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Acetylcysteine Solution 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Acetylcysteine Solution 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Allopurinol Suspension 20 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Allopurinol Suspension 20 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Alprazolam Suspension 1 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Alprazolam Suspension 1 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

CH 1.5 Aminoglycoside Antibiotics

John E. Murphy

Restricted access

CH 2.5 Aminoglycoside Antibiotics

John E. Murphy

Restricted access

8 AMINOGLYCOSIDES

Kathryn R. Matthias and John E. Murphy

Restricted access

Amiodarone Hydrochloride Suspension 5 mg/mL—Formulation 1*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Amiodarone Hydrochloride Suspension 5 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Amitriptyline Hydrochloride Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Amitriptyline Hydrochloride Suspension 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Amitriptyline Hydrochloride Syrup 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Amlodipine Besylate Suspension 1 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Amlodipine Besylate Suspension 1 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Amphetamine and Dextroamphetamine (Adderall) Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

9 ANTIDEPRESSANTS

Patrick R. Finley

Restricted access

10 ANTIEPILEPTICS

Jacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin

Restricted access

11 ANTIREJECTION AGENTS

Tony K.L. Kiang

Restricted access

APPENDICES

John E. Murphy

Restricted access

Appendix

John E. Murphy

Restricted access

APPENDIX A

John E. Murphy

Restricted access

APPENDIX B

John E. Murphy

Restricted access

Aprepitant Suspension 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Aripiprazole Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

13 Arterial Blood Gases and Acid–Base Balance

Jeffrey F. Barletta

Restricted access

2 ASSESSMENT OF KIDNEY FUNCTION

Joanna Q. Hudson

Restricted access

Atenolol Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Atenolol Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Atenolol Syrup 2 mg/mL—Formulation 1*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Atenolol Syrup 2 mg/mL—Formulation 2*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Atropine Sulfate Suspension 0.1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Azathioprine Suspension 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Baclofen Suspension 10 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Baclofen Suspension 10 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Baclofen Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Baclofen Syrup 5 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

SECTION 1: Basic Concepts and Special Populations

John E. Murphy